Thiem VD, Anh DD, Ha VH, Van Thom N, et al. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial. Vaccine 2024;44:126542.
PMID: 39615342